Clinical trials in Ratingen – page 3

Multiple clinical trials focusing on psoriatic arthritis (PsA) treatment innovations, including studies of novel therapies like zasocitinib, bimekizumab, and guselkumab for managing active disease symptoms.

• Treatment efficacy evaluation
• Long-term safety assessment
• Biologic-naive patient studies

Research aims to improve treatment options and reduce symptoms in patients with varying disease severity levels.

Ongoing investigations into rheumatoid arthritis treatments, featuring comparative studies of medications like upadacitinib and adalimumab, with particular focus on patients who have had inadequate response to previous treatments.

• Comparative treatment efficacy
• Long-term medication safety
• Treatment switching outcomes

These studies aim to expand therapeutic options for patients with moderate to severe disease.

Comprehensive research into various inflammatory conditions including polymyalgia rheumatica and axial spondyloarthritis, evaluating new treatment approaches and maintenance therapies.

• Disease remission studies
• Novel treatment evaluations
• Extended safety monitoring

Focus on developing sustainable long-term treatment solutions for chronic inflammatory conditions.